创新政策与区域创新环境协同：香港纽约生物医药产业对比

Coordination between Innovation Policy and Regional Innovation Environment: A Case Study of the Biopharma Industry in Hong Kong and New York City

摘要:

生物医药是香港重点发展的产业领域,也是香港建设国际创新科技中心的重要创新领域,特区政府为促进生物医药产学研发展制定了一系列创新政策。本文将香港与近年同样致力于发展生物医药产业,且取得了较好成果的纽约市对比,发现香港的创新政策力度虽大,但生物医药创新环境仍有提升空间,存在创新经济的金融服务能力不够强、创新要素跨境流动需改善、区域创新网络不够密集等问题,并提出了加快改善创新环境的对策建议。

Abstract:

Biopharma industry stands as a key focus area for development in Hong Kong and is pivotal in its aspiration to become an international innovation and technology center. The Special Administrative Region (SAR) government has implemented a series of innovative policies to foster the growth of biopharma research, education, and industry-academia collaborations. This paper juxtaposes the efforts of Hong Kong with those of New York City, which has also made significant strides in biopharma industry development in recent years. While Hong Kong"s innovation policies demonstrate considerable vigor, the study reveals areas for enhancement in the biopharma innovation ecosystem. Key challenges include the inadequacy of financial services to support innovation-driven economy, the need for improvement in cross-border flow of innovation elements, and the insufficiency of regional innovation networks. The paper concludes by proposing strategic recommendations to expedite the enhancement of the innovation ecosystem.